Lite Strategy (LITS) Net Margin (2016 - 2023)
Lite Strategy (LITS) posted Net Margin of 86.34% for Q3 2023, up 112.56% on a QoQ basis from 687.51% in Q2 2023, and up 28953.0% year-over-year from N/an in Q3 2022.
Powered by 
Analysis
Lite Strategy (LITS) Net Margin (2016 - 2023) Analysis & Trends
Lite Strategy has reported Net Margin for 8 years, with the latest figure at 86.34% in Q3 2023.
- On a quarterly basis, Net Margin rose 28953.0% year-over-year to 86.34% in Q3 2023; TTM through Jun 2024 was 27.29%, a 9575.0% increase from a year earlier, with the FY2024 full-year figure at 27.29%, up 9575.0% from the prior year.
- Net Margin was 86.34% for Q3 2023 at Lite Strategy, up from 687.51% in the prior quarter.
- The five-year high for Net Margin was 270.42% in Q2 2019, with the low at 2005.65% in Q4 2019.
- Average Net Margin over 5 years is 332.96%, with a median of 207.42% recorded in 2021.
- The largest YoY upside for Net Margin was 378374 bps in 2019 against a maximum downside of 259253 bps in 2019.
- Over 5 years, Net Margin stood at 2005.65% in 2019, then jumped by 95 bps to 90.94% in 2020, then sank by 64 bps to 148.87% in 2021, then surged by 120 bps to 29.85% in 2022, then soared by 189 bps to 86.34% in 2023.
- The last three Net Margin figures came in at 86.34% (Q3 2023), 687.51% (Q2 2023), and 261.86% (Q1 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 23.62% |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -134.51% |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 32.99% |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 30.23% |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 31.16% |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -539.31% |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 12.74% |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 3.56% |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -20,152.98% |
| 10 | Lite Strategy | 38.03 Mn | 30.49 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 86.34% |
| Jun 30, 2023 | -687.51% |
| Mar 31, 2023 | -261.86% |
| Dec 31, 2022 | 29.85% |
| Sep 30, 2022 | -203.20% |
| Jun 30, 2022 | -140.09% |
| Mar 31, 2022 | -221.77% |
| Dec 31, 2021 | -148.87% |
| Sep 30, 2021 | -259.08% |
| Jun 30, 2021 | -207.42% |
| Mar 31, 2021 | -386.15% |
| Dec 31, 2020 | -90.94% |
| Sep 30, 2020 | -31.52% |
| Jun 30, 2020 | -72.44% |
| Mar 31, 2020 | -347.99% |
| Dec 31, 2019 | -2,005.65% |
| Sep 30, 2019 | -258.77% |
| Jun 30, 2019 | 270.42% |
| Mar 31, 2019 | -1,389.51% |
| Dec 31, 2018 | 586.87% |